1. Kaempferol targets estrogen‑related receptor α and suppresses the angiogenesis of human retinal endothelial cells under high glucose conditions
    Yan Wu et al, 2017, Experimental and Therapeutic Medicine CrossRef
  2. Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease
    Vincenzo Raimondi et al, 2022, Frontiers in Oncology CrossRef
  3. Inhibition of PGC-1α after chemotherapy-mediated insult confines multiple myeloma cell survival by affecting ROS accumulation
    DEDONG CAO et al, 2015, Oncology Reports CrossRef
  4. Pterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells
    Huiling Mei et al, 2018, International Journal of Molecular Medicine CrossRef
  5. Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
    Danielle Harmer et al, 2019, Frontiers in Endocrinology CrossRef
  6. A review on the treatment of multiple myeloma with small molecular agents in the past five years
    Zhenzhen Zhang et al, 2022, European Journal of Medicinal Chemistry CrossRef
  7. Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study
    Cécile Héliès-Toussaint et al, 2014, Toxicology and Applied Pharmacology CrossRef
  8. Aqueous Extract of Paris polyphylla (AEPP) Inhibits Ovarian Cancer via Suppression of Peroxisome Proliferator-Activated Receptor-Gamma Coactivator (PGC)-1alpha
    Chia-Woei Wang et al, 2016, Molecules CrossRef
  9. Cancer metabolism in space and time: Beyond the Warburg effect
    Pierre Danhier et al, 2017, Biochimica et Biophysica Acta (BBA) - Bioenergetics CrossRef
  10. PGC-1α is responsible for survival of multiple myeloma cells under hyperglycemia and chemotherapy
    WEN YU et al, 2015, Oncology Reports CrossRef
  11. NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells
    ZIHAN XU et al, 2016, Oncology Reports CrossRef
  12. ERRα Attenuates Vascular Inflammation via Enhanced NFκB Degradation Pathway
    Hiroyasu Yamamoto et al, 2023, Endocrinology CrossRef
  13. SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation
    Yu Xiang et al, 2020, Life Sciences CrossRef
  14. AMPKα2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment
    Yuan Huang et al, 2022, Biochemical Pharmacology CrossRef
  15. Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells
    Carolyne Falank et al, 2016, Frontiers in Endocrinology CrossRef
  16. Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma
    Timon A. Bloedjes et al, 2021, Cancers CrossRef
  17. AMPK/PGC-1α/GLUT4-Mediated Effect of Icariin on Hyperlipidemia-Induced Non-Alcoholic Fatty Liver Disease and Lipid Metabolism Disorder in Mice
    Wei Lin et al, 2021, Biochemistry (Moscow) CrossRef
  18. PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors
    Chi Luo et al, 2016, Trends in Cancer CrossRef
  19. Glucose transporters: Important regulators of endometrial cancer therapy sensitivity
    Xing Zhang et al, 2022, Frontiers in Oncology CrossRef